Product NDC: | 64661-070 |
Proprietary Name: | J-MAX |
Non Proprietary Name: | Dihydrocodeine Bitartrate, Guaifenesin |
Active Ingredient(s): | 7.5; 100 mg/5mL; mg/5mL & nbsp; Dihydrocodeine Bitartrate, Guaifenesin |
Administration Route(s): | ORAL |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 64661-070 |
Labeler Name: | JayMac Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20080630 |
Package NDC: | 64661-070-16 |
Package Description: | 473 mL in 1 BOTTLE (64661-070-16) |
NDC Code | 64661-070-16 |
Proprietary Name | J-MAX |
Package Description | 473 mL in 1 BOTTLE (64661-070-16) |
Product NDC | 64661-070 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Dihydrocodeine Bitartrate, Guaifenesin |
Dosage Form Name | LIQUID |
Route Name | ORAL |
Start Marketing Date | 20080630 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | JayMac Pharmaceuticals |
Substance Name | DIHYDROCODEINE BITARTRATE; GUAIFENESIN |
Strength Number | 7.5; 100 |
Strength Unit | mg/5mL; mg/5mL |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |